Receive a study payment of up to £1,436
We are conducting a clinical trial for a potential new medicine that could be used to treat people with cancer (cutaneous T-cell lymphoma). In this study, we are asking healthy male volunteers aged 18 to 40 years to test the drug so we can see how well tolerated the medicine is and how long it stays in your body. You will be paid for your time and commitment if you participate in this clinical trial.
If you are interested in participating in the trial:-
This trial will involve you staying with us for a few days (see below) at our private medical facility in London Bridge.
- You will need to attend a screening appointment so we can check if you are suitable to take part in the trial. At this appointment we perform a number of tests including taking blood samples, checking your heart and carrying out a physical examination to see if it will be OK for you to take part in the study.
- If results from your screening appointment show you are a good candidate for the trial, you will be invited to take part.
- This will involve a stay of 4 days / 3 nights in our research unit.
- The new medicine will be given to you once by injection.
- After your stay with us you will be required to return for 4 follow-up visits on Days 8, 15, 22, and 29 of the study. This means the whole process takes approximately 6 weeks from your screening visit through to your final visit.
- In total, if you are included in the study you will come to the research unit 6 times
- During your stay with us you will receive the single dose of the new medicine and we will conduct a number of assessments (repeats of the tests we did at screening) to check how well you tolerate the drug and to help us understand how your body processes and then gets rid of the drug. We will also perform a biopsy (i.e. remove a small piece of skin from a discrete area of your back or thigh) on Days 1, 2, 8, and 15 of the study.
- On the four days you are not required to attend the unit, a text messaging system will be used to conduct a check-up assessment until your next visit to the unit.
Register your interest in this clinical trial
*Only 1x screening appointment required
Who can take part?
We will check your suitability for the clinical trial using the following criteria:-
- You are a male aged between 18 to 40 years inclusive.
- You have a Body Mass Index (BMI) within the range of 18.0 and 25.0 kg/m2.
- You must be healthy with no underlying medical conditions that may affect the trial or put you at any significant risk.
- If you are sexually active, you must be willing to use appropriate contraception, starting from the first day of dosing until 6 months later.
- You must be a non-smoker/non-user of nicotine or a light smoker/user of nicotine (defined as ≤10 cigarettes per day).
- You must not test positive for alcohol or drugs or show any evidence of drug or alcohol abuse (Alcohol abuse is defined as a regular weekly intake of more than 14 units).
- You must not have a tattoo or body piercing which might interfere with the injection site examination throughout the clinical trial.
- You must not have any abnormal findings that could make your skin unsuitable for biopsy (a sample of tissue taken from the body) including tattoos, scars, acne, burn, or underlying skin condition.
- You must not have any known wound healing disorders such as keloids (a thick, lumpy, raised scar which grows past the wound and into the surrounding skin), hypertrophic scarring (a thick, raised scar which is a natural response to wound healing) or delayed wound healing.
A full list of acceptable contraceptive methods will be discussed in full by a member of the recruitment team and a trial doctor during screening.
Clinical trial Payment
If you take part in the trial, i.e. you take the study medication, complete all visits and follow the study rules, you will receive £1,436 (£958 clinical trial payment and £478 bonus) on completion of the clinical trial.
Contact our Volunteer Recruitment team
For more information call +44 (0) 20 7042 5800 or email:Register your interest in this clinical trial
You may be required to remain resident in the unit until resolution of any safety issues, after which you will be discharged from the unit.
The contents of this page have been approved by an ethics committee. Any response to this advertisement will be recorded. Your response will not place you under any obligation to participate in this trial.
Ref: C20006_Jun2020 (email_website_advert text)